Harry E Fuentes
Overview
Explore the profile of Harry E Fuentes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fuentes H, Suleiman R, Graham R, Villasboas Bisneto J, Garcia J, Halfdanarson T
Oncologist
. 2024 Dec;
PMID: 39721045
Background: Sarcomatoid carcinomas (SC) are rare tumors with both epithelial and mesenchymal characteristics, linked to aggressive behavior and poor prognosis. Sarcomatoid carcinoma of unknown primary (SCUP) is an exceedingly rare...
2.
Baral B, Suleiman R, Fazer-Posorske C, Ma D, McGarrah P, Thome S, et al.
Head Neck
. 2024 Jul;
46(10):E84-E90.
PMID: 39032143
Background: Head and neck cancers (HNC) present diagnostic challenges due to multifocal disease manifestations, posing difficulties in distinguishing between metastatic disease and second primary malignancies (SPM). This complexity underscores the...
3.
Riaz I, Fuentes H, Naqvi S, He H, Sipra Q, Tafur A, et al.
Mayo Clin Proc
. 2021 Jun;
97(2):308-324.
PMID: 34172290
Objective: To maintain living, interactive evidence (LIvE) on the benefits and harms of different treatment options in adults with cancer-associated thrombosis (CAT). Methods: We have used a novel LIvE synthesis...
4.
Fuentes H, McBane 2nd R, Wysokinski W, Tafur A, Loprinzi C, Murad M, et al.
Mayo Clin Proc
. 2019 Nov;
94(12):2444-2454.
PMID: 31685262
Objective: To explore the efficacy and safety of direct oral factor Xa inhibitors in the treatment of cancer-associated acute venous thromboembolism (VTE). Patients And Methods: MEDLINE, CENTRAL (Cochrane Central Register...
5.
Duma N, Durani U, Woods C, Kankeu Fonkoua L, Cook J, Wee C, et al.
J Clin Oncol
. 2019 Oct;
37(36):3538-3545.
PMID: 31603705
Purpose: In a professional setting, the introduction of female speakers without their professional title may have an impact on the public's perception of the female speaker. We examined how professional...
6.
Katiyar V, Uprety A, Mendez-Hernandez A, Fuentes H, Andrade X, Zia M
TH Open
. 2019 Jul;
3(3):e203-e209.
PMID: 31321378
Patients with Philadelphia-negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (MF), have a significant risk of venous thromboembolism (VTE). We aim to determine the...
7.
Torres C, Fuentes H, Saadaldin H, Salazar J, Paz L, Diaz L, et al.
Hemodial Int
. 2019 Jul;
23(4):433-444.
PMID: 31283096
Introduction: Patients with end-stage renal disease (ESRD) experience frequent hemodialysis (HD) complications. Intradialytic hypotension (IDH) is a common complication presenting in approximately between 20 and 50% of HD sessions. Available...
8.
Majmudar K, Quintero L, Fuentes H, Stocker S, Tafur A, Lee C, et al.
J Surg Oncol
. 2019 Jun;
120(3):494-500.
PMID: 31222842
Background And Objectives: Pancreatic cancer is strongly associated with thrombosis. We investigated early postoperative venous thromboembolism (PVTE) mortality among patients with pancreatic surgery and compared outcomes in adenocarcinoma pancreatic cancer...
9.
Golemi I, Salazar Adum J, Diaz Quintero L, Paz L, Fuentes H, Schmitt N, et al.
Int Angiol
. 2019 Jun;
38(4):284-290.
PMID: 31203596
Background: Venous thromboembolism (VTE) includes pulmonary embolism (PE) and deep vein thrombosis (DVT), and results in 100,000 deaths annually in the United States. There is low global VTE awareness, including...
10.
Diaz Quintero L, Fuentes H, Tafur A, Majmudar K, Salazar Adum J, Golemi I, et al.
Int Angiol
. 2019 May;
38(3):194-200.
PMID: 31112026
Background: The aim of this study was to define the association of non-adenocarcinoma pancreatic cancer (NACPC) as a risk factor for postoperative cancer-associated thrombosis (CAT). Methods: We conducted analysis of...